Apop Biosciences

Apop Biosciences is at the forefront of biotechnology research, powering cell stress detection with world-class innovative technologies. Apop Biosciences' breakthrough CalRexin® technologies are transforming the understanding of complex cell stress mechanisms associated with programmed cell death (PCD) and autophagy, crucial for addressing several significant diseases.

Apop Biosciences has launched a pipeline of proprietary novel imaging reagents to interrogate these mechanisms, paving the way for a range of emerging therapeutics and diagnostics products. All Apop Biosciences products are based on the proprietary calcitonin receptor antibody technology, CalRexin®, that targets a novel extracellular marker of these complex processes, accumulates into live stressed cells, and is proven for the detection of apoptosis and autophagy.

Located primarily in Melbourne, AU, Apop Biosciences continues to innovate and expand its impact on the biotechnology landscape. We invite the management team at Apop Biosciences to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and commercial development.